Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar? - Yahoo Finance
3 weeks ago • Google News
Harrow Health Inc (HROW)
US$ 42.446.9%
Price Chart
Key Statistics
Market Cap
$ 1.17B
P/E Ratio
0.00
Revenue (TTM)
$ 212.86M
Volume
585.84K
52W High
$ 59.23
52W Low
$ 20.85
Dividend Yield
0.00%
Beta
0.41
Technicals
50-Day MA
31.5452
200-Day MA
33.1461
52 Week High
59.23
52 Week Low
20.85
About HROW
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
Employees
382
Headquarters
Nashville, TN
CEO
Mr. Mark L. Baum J.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg